GNAS is a gene that helps control how cells respond to outside signals. It appears on pathology reports when testing has found a change, or mutation, in the gene. GNAS is part of a molecular switch just inside the cell membrane. When a hormone or other signal arrives at the surface, this switch turns on briefly, passes the message inward, and then shuts itself off. Shutting off is as important as turning on.
What does a GNAS mutation do?
Mutations in tumors disable the off setting. The switch turns on normally but cannot turn itself off, so the cell behaves as though a signal were arriving constantly. In glandular cells, one consequence is a large increase in mucin production. This is why GNAS mutations are so characteristic of tumors that make thick, jelly-like material.
These mutations are almost always acquired during life rather than inherited. They arise in the tumor cells themselves and are not passed to children.
Which tumors carry GNAS mutations?
- Appendix. Most low-grade appendiceal mucinous neoplasms carry a GNAS mutation, usually alongside a KRAS mutation.
- Pancreas. GNAS mutations are common in intraductal papillary mucinous neoplasms, and finding one in cyst fluid helps confirm what type of cyst is present.
- Colon and rectum. Found in a minority of tumors, most often those producing large amounts of mucin.
- Bone. A GNAS mutation present in only some cells of the body causes fibrous dysplasia, in which normal bone is replaced by fibrous tissue. When this occurs with skin pigmentation and hormone problems, it is called McCune-Albright syndrome.
Why do pathologists test for GNAS?
Pathologists use GNAS testing to help make or confirm a diagnosis rather than to select a treatment. Its most common use is in evaluating a pancreatic cyst. Fluid drawn from the cyst can be tested for the mutation. A GNAS result points strongly toward one particular type of cyst rather than another, and that distinction affects whether the cyst is watched or removed.
In tumors of the appendix, GNAS is more often part of a broader panel of genes tested together. It confirms what the pathologist already sees under the microscope rather than changing the plan.
No drug currently targets a GNAS mutation directly. A GNAS result on your report is information about what your tumor is, not a signpost toward a particular therapy.
How is the test performed?
GNAS testing is done on tissue already removed at biopsy or surgery, or on fluid drawn from a cyst. It usually forms part of a panel examining many genes at once, often by next-generation sequencing.
Because the test is performed on tissue, no additional procedure is normally needed. Results typically take one to several weeks and often arrive separately from the main pathology report.
Questions to ask your doctor
- Why was GNAS testing performed on my sample?
- Was a GNAS mutation found?
- What does this result tell us about my diagnosis?
- Does this result change my treatment?
- Were other genes tested at the same time, and what did they show?
- Is this mutation something my family members could inherit?
- Will this result be repeated or checked again in the future?
Related articles on MyPathologyReport.com
We are proud to partner with:
🔍 Search MyPathologyReport
Type what you see on your report — for example a diagnosis or test name